OBJECTIVES/HYPOTHESIS We aimed to assess voice outcomes following reoperative central neck dissection (RCND) to characterize postoperative voice difficulties experienced, determine the natural progression of vocal recovery, and identify risk factors for the development of voice disorders postoperatively. STUDY DESIGN Prospective cohort study. METHODS Consecutive patients with recurrent/pers...

Iodine-131 (131I) plays an important role in the management of patients with well-differentiated thyroid cancers. Post-thyroidectomy ablation therapy with 131I is performed to destroy the small amount of thyroid tissue remaining in the neck after surgery [8,14]. The use of radioiodine for ablation has been shown to decrease the risk of recurrence, increase the sensitivity of post-ablation whole...

Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for preparation of thyroid remnant ablation with radioactive iodine (RAI) in low risk patients with well differentiated thyroid cancer (DTC). We studied the safety and efficacy of rhTSH preparation for RAI treatment of thyroid cancer patients with nodal metastatic disease. Methods. A retrospective analysis was perfo...

UNLABELLED Follow-up diagnostic radioiodine whole-body scintigraphy (DxWBS) is still advised for high-risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the additional value of DxWBS to stimulated thyroglobulin measurement in high-risk patients. METHODS The results of DxWBS and thyroglobulin measurements performed 6-12 mo after surgery and radioiodine thyr...

Thyroid cancer and Graves' disease may present simultaneously in one patient. The incidence of the development of hyperthyroidism from metastatic differentiated thyroid carcinoma is rare. We herein report a case of metastatic follicular carcinoma complicated with Graves' disease after total thyroidectomy. A 57-year-old woman underwent right hemithyroidectomy for follicular carcinoma. Metastatic...

OBJECTIVE The consensus about optimal activities of I-131 for thyroid remnant ablation has not yet been achieved. The aim of this study was to compare ablation rates obtained with different I-131 activities. PATIENTS AND METHODS The study included 466 patients divided into four groups according to I-131 activities given after total thyroidectomy for papillary thyroid cancer: group A [168 pati...

AIM The aim of this study was to compare the efficacy and adverse effects of radioiodine (131I) therapy between two groups of patients with low-risk differentiated thyroid cancer (DTC) who received 30 mCi or 100 mCi radioiodine for ablation of the thyroid remnant after total thyroidectomy. METHODS The study cohort was 173 patients, 85 of whom were given 30 mCi of radioiodine and the others we...

Objective: The current work was conducted to study the disease status and treatment results of patients with differentiated thyroid carcinoma referred for surgery and for radioactive iodine therapy. Methods: Retrospective review of 174 patients with differentiated thyroid carcinoma referred for surgery and for radioactive iodine therapy in King abulaziz Hospital and Oncology Center, Jeddah, Sau...